학술논문

P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE‐CEL, BB2121), A BCMA‐DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL.
Document Type
Article
Source
HemaSphere; Apr2022 Supplement 1, Vol. 6, p21-22, 2p
Subject
Language
ISSN
25729241